American Academy of Pediatric Dentistry Pulp therapy for primary and immature permanent teeth. The Reference Manual of Pediatric Dentistry. Chicago, Ill.: American Academy of Pediatric Dentistry; 2022:415-23
Bogen G, Dammaschke T, Chandler N Vital pulp therapy. In: Berman L, Hargreaves KM, editors. Pathways of the Pulp. 12th ed. St. Louis, MO: Elsevier; 2021.
Guan X, Zhou Y, Yang Q, Zhu T, Chen X, Deng S, Zhang D Vital Pulp Therapy in Permanent Teeth with Irreversible Pulpitis Caused by Caries: A Prospective Cohort Study. J Pers Med. 2021 Nov 1;11(11):1125. doi: 10.3390/jpm11111125.
Parmar G, Singh S, Hegde JA, Kumar M, Kalyan S Launching a new fellowship in microrestorative and endodontics for postgraduates in conservative dentistry and endodontics. J Conserv Dent. 2020 Jul-Aug;23(4):370-373. doi: 10.4103/JCD.JCD_328_20. Epub 2021 Jan 16.
Wisniewski JF, Norooz S, Callahan D, Mohajeri A Survey of Vital Pulp Therapy Treatment in Permanent Dentition Being Taught at U.S. Dental Schools. J Endod. 2022 Sep;48(9):1107-1112. doi: 10.1016/j.joen.2022.06.009. Epub 2022 Jul 5.
Knowledge of Vital Pulp Therapy in Permanent Teeth Among a Group of Dental Students in Egypt: A Cross-sectional Study.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
